Acute kidney injury in patients with cancer

MH Rosner, MA Perazella - New England Journal of Medicine, 2017 - Mass Medical Soc
Acute Kidney Injury in Patients with Cancer | New England Journal of Medicine Skip to main
content The New England Journal of Medicine homepage Advanced Search SEARCH …

Management of multiple myeloma-related renal impairment: recommendations from the International Myeloma Working Group

MA Dimopoulos, G Merlini, F Bridoux, N Leung… - The Lancet …, 2023 - thelancet.com
Summary Here, the International Myeloma Working Group (IMWG) updates its clinical
practice recommendations for the management of multiple myeloma-related renal …

NCCN guidelines insights: Multiple myeloma, version 1.2020: Featured updates to the NCCN guidelines

SK Kumar, NS Callander, J Hillengass… - Journal of the National …, 2019 - jnccn.org
The NCCN Guidelines for Multiple Myeloma provide recommendations for diagnosis,
workup, treatment, follow-up, and supportive care for patients with monoclonal gammopathy …

Oral ixazomib, lenalidomide, and dexamethasone for transplant-ineligible patients with newly diagnosed multiple myeloma

T Facon, CP Venner, NJ Bahlis, F Offner… - Blood, The Journal …, 2021 - ashpublications.org
Abstract Continuous lenalidomide-dexamethasone (Rd)-based regimens are among the
standards of care in transplant-ineligible newly diagnosed multiple myeloma (NDMM) …

Effect of high-cutoff hemodialysis vs conventional hemodialysis on hemodialysis independence among patients with myeloma cast nephropathy: a randomized clinical …

F Bridoux, PL Carron, B Pegourie, E Alamartine… - Jama, 2017 - jamanetwork.com
Importance Cast nephropathy is the main cause of acute kidney injury in multiple myeloma
and persistent reduction in kidney function strongly affects prognosis. Strategies to rapidly …

Current approaches to management of newly diagnosed multiple myeloma

U Goel, S Usmani, S Kumar - American journal of hematology, 2022 - Wiley Online Library
Major developments in the treatment of multiple myeloma (MM) over the past decade have
led to a continued improvement in survival. Significant progress has been made with deeper …

High cutoff versus high-flux haemodialysis for myeloma cast nephropathy in patients receiving bortezomib-based chemotherapy (EuLITE): a phase 2 randomised …

CA Hutchison, P Cockwell, V Moroz… - The Lancet …, 2019 - thelancet.com
Background In multiple myeloma, severe acute kidney injury due to myeloma cast
nephropathy is caused by pathogenic free light chain immunoglobulin in serum. High cutoff …

Management of acute kidney injury in symptomatic multiple myeloma

F Bridoux, N Leung, M Belmouaz, V Royal, P Ronco… - Kidney international, 2021 - Elsevier
Symptomatic multiple myeloma is commonly complicated by acute kidney injury through
various mechanisms. The most frequent is the precipitation of monoclonal free light chains …

Utilization of hematopoietic stem cell transplantation for the treatment of multiple myeloma: a Mayo Stratification of Myeloma and Risk-Adapted Therapy (mSMART) …

WI Gonsalves, FK Buadi, S Ailawadhi… - Bone marrow …, 2019 - nature.com
Over the last two decades, the utilization of various novel therapies in the upfront or salvage
settings has continued to improve survival outcomes for patients with Multiple Myeloma …

[HTML][HTML] From transplant to novel cellular therapies in multiple myeloma: European Myeloma Network guidelines and future perspectives

F Gay, M Engelhardt, E Terpos, R Wäsch… - …, 2018 - ncbi.nlm.nih.gov
Survival of myeloma patients has greatly improved with the use of autologous stem cell
transplantation and novel agents, such as proteasome inhibitors, immunomodulatory drugs …